Skip to main content
Summary
Profile
Financials
Events
Ownership
Options

Competitors

SymbolLastChange
VVOS2.19-0.11 (-4.78%)
PAE10.000.01 (0.10%)
TLS13.29-0.34 (-2.53%)
QNST15.57-0.01 (-0.06%)
HSII42.57-0.12 (-0.28%)

Company Info

Industry Miscellaneous Commercial Services
Sector Commercial Services
Employees 98
CEO Mr. R. Kirk Huntsman
Address 9137 South Ridgeline Boulevard Suite 135, Highlands Ranch, CO 80129
Phone 1.866.908.4867
Website www.vivoslife.com

Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Highlands Ranch, CO.

Statement Summary

as of 4:00 ET PM 01/19/2022
Total Assets (MRQ) 41.0 M
Total Liabilities (MRQ) 8.6 M
Shareholders’ Equity (MRQ) 32.5 M
Total Revenue (Annual) 4.5 M
Net Income (Annual) -5.5 M

Earnings And Estimates

as of 4:00 ET PM 01/19/2022

Current Qtr EPS Estimate -0.25
Current FY EPS Estimate -0.90
Long Term EPS Growth Estimate 7.00
Next Expected Earnings Date 3/24/2022

VVOS vs S&P 500

as of 01/19/2022
Relative To
S&P 500
VVOS
4 Weeks n/a n/a
12 Weeks n/a n/a
YTD n/a n/a

Earnings Surprises

as of 4:00 ET PM 01/19/2022
Fiscal Quarter Estimate Actual Surprise
09/2021 -0.19 -0.26 +40.54%
06/2021 -0.18 -0.19 +5.56%
03/2021 -0.17 -0.19 +11.76%
12/2020 -0.17 -0.55 +230.30%

Financial Strength

as of 4:00 ET PM 01/19/2022
Pre-Tax Margin -119.96
Net Margin -117.77
Operating Margin -121.04
Return On Equity -140.13
Return On Assets -91.87
Inventory Turnover (TTM) 0.00
Sales Growth (MRQ) n/a

Ratios

as of 4:00 PM ET 01/19/2022
Price/Earnings (TTM) n/a
Price/Book (MRQ) 1.33
Price/Cash Flow (TTM) 0.00
Book Value (MRQ) 1.41
Quick Ratio (MRQ) 4.15
Current Ratio (MRQ) 4.15
Total Debt/Equity (MRQ) 0.04

Short Interest

as of 3:27 PM ET 01/20/2022
% Short - 0.00%
% Remaining Float - 100.00%
Current Last Month
Short Interest Date n/a n/a
Short Interest Shares 0 0
Short Interest Ratio 0.0 0.0
M Y M Y
Total Assets 0,0.00 0,0.00
Total Liabilities 0,0.00 0,0.00
Total Equity 0,0.00 0,0.00
M Y M Y
Total Revenue 0,0.00 0,0.00
EBT Exc.
Unusual Items
0,0.00 0,0.00
Net Income 0,0.00 0,0.00
M Y M Y
Cash from
Operations
0,0.00 0,0.00
Cash from
Activities
0,0.00 0,0.00
Cash from
Fin. Activities
0,0.00 0,0.00

TOTAL ASSETS

TOTAL LIABILITIES

TOTAL EQUITY

Balance Sheet

M Y
ASSETS
Cash And Equivalents 0,0.00
Receivables 0,0.00
Inventories 0,0.00
Other Current Assets 0,0.00
Total Current Assets 0,0.00
Property, Plant & Equipment, Gross 0,0.00
Accumulated Depreciation & Depletion 0,0.00
Property, Plant & Equipment, Net 0,0.00
Intangibles 0,0.00
Other Non-Current Assets 0,0.00
Total Non-Current Assets 0,0.00
TOTAL ASSETS 0,0.00
Liabilities & Shareholder Equity
Accounts Payable 0,0.00
Short Term Debt 0,0.00
Total Current Liabilities 0,0.00
Long Term Debt 0,0.00
Deferred Income Taxes 0,0.00
Other Non-Current Liabilities 0,0.00
Minority Interest 0,0.00
Total Non-Current Liabilities 0,0.00
Preferred Stock Equity 0,0.00
Common Stock Equity 0,0.00
Common Par 0,0.00
Additional Paid In Capital 0,0.00
Cumulative Translation Adjustment 0,0.00
Retained Earnings 0,0.00
Treasury Stock 0,0.00
Other Equity Adjustments 0,0.00
Total Capitalization 0,0.00
TOTAL EQUITY 0,0.00
TOTAL LIABILITIES & STOCK EQUITY 0,0.00
Total Common Shares Outstanding 0,0.00
Preferred Shares 0,0.00
Treasury Shares 0,0.00
Basic Weighted Shares Outstanding 0,0.00
Diluted Weighted Shares Outstanding 0,0.00
Number Of Employees 0,0.00
Number Of Part-Time Employees 0,0.00

TOTAL REVENUES

EBT Excluding Unusual Items

NET INCOME

Income Statement

M Y
Sales 0,0.00
Cost Of Sales 0,0.00
Gross Operating Profit 0,0.00
Selling, General, And Administrative Expenses 0,0.00
Research & Development 0,0.00
Operating Income Before D & A (EBITDA) 0,0.00
Depreciation & Amortization 0,0.00
Interest Income 0,0.00
Other Income - Net 0,0.00
Special Income / Charges 0,0.00
Total Income Before Interest Expenses (EBIT) 0,0.00
Interest Expense 0,0.00
Pre-Tax Income 0,0.00
Income Taxes 0,0.00
Minority Interest 0,0.00
Net Income From Continuing Operations 0,0.00
Net Income From Discontinued Operations 0,0.00
Net Income From Total Operations 0,0.00
Extraordinary Income/Losses 0,0.00
Income From Cum. Effect Of Acct. Change 0,0.00
Income From Tax Loss Carryforward 0,0.00
Other Gains / Losses 0,0.00
Total Net Income 0,0.00
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Preferred Dividends 0,0.00
Net Income Available To Common 0,0.00
Basic EPS From Continuing Ops. 0,0.00
Basic EPS From Discontinued Ops. 0,0.00
Basic EPS From Total Operations 0,0.00
Basic EPS From Extraordinary Inc. 0,0.00
Basic EPS From Cum Effect Of Accounting Change 0,0.00
Basic EPS From Tax Loss Carryf'd. 0,0.00
Basic EPS From Other Gains (Losses) 0,0.00
Basic EPS, Total 0,0.00
Basic Normalized Net Income/Share 0,0.00
EPS From Continuing Ops. 0,0.00
EPS From Discontinued Ops 0,0.00
EPS From Total Ops. 0,0.00
EPS From Extraord. Inc. 0,0.00
EPS From Cum Effect of Accounting Change 0,0.00
EPS From Tax Loss Carfd. 0,0.00
EPS From Other Gains (L) 0,0.00
EPS, Total 0,0.00
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0,0.00
Dividends Paid Per Share 0,0.00

CASH FROM OPERATIONS

CASH FROM INVESTING ACTIVITIES

CASH FROM FINANCING ACTIVITIES

Cash Flow Statement

M Y
Cash Flow From Operating Activities
Net Income (Loss) 0,0.00
Operating Gains/Losses 0,0.00
Gross Operating Profit 0,0.00
(Increase) Decrease In Receivables 0,0.00
(Increase) Decrease In Inventories 0,0.00
(Increase) Decrease In Other Current Assets 0,0.00
(Decrease) Increase In Other Current Liabilities 0,0.00
(Increase) Decrease In Other Working Capital 0,0.00
Other Non-Cash Items 0,0.00
Net Cash From Continuing Operations 0,0.00
Net Cash From Discontinued Operations 0,0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 0,0.00
Sale Of Property, Plant & Equipment 0,0.00
Cash Used For Investing Activities
Sale Of Short-Term Investments 0,0.00
Purchases Of Property, Plant & Equipment 0,0.00
Acquisitions 0,0.00
Purchases Of Short-Term Investments 0,0.00
Other Cash From Investing Activities 0,0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities 0,0.00
Issuance Of Debt 0,0.00
Cash Used For Financing Activities
Issuance Of Capital Stock 0,0.00
Repayment Of Long-Term Debt 0,0.00
Repurchase Of Capital Stock 0,0.00
Payment Of Cash Dividends 0,0.00
Other Financing Charges, Net 0,0.00
Net Cash From Financing Activities 0,0.00
Effect Of Exchange Rate Changes 0,0.00
Net Change In Cash & Cash Equivalents 0,0.00

Earnings Estimates

as of 4:00 ET PM 01/19/2022
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Consensus Estimate $-0.25 $-0.26
# of Estimates 2 1
High Estimate $-0.23 $-0.26
Low Estimate $-0.27 $-0.26
Year Ago EPS $-0.19 $-0.19
Year Over Year Growth Estimate 33.90% 39.26%
Current Yr
(12/2021)
Next Yr
(12/2022)
Consensus Estimate $-0.90 $-0.86
# of Estimates 2 2
High Estimate $-0.88 $-0.65
Low Estimate $-0.92 $-1.07
Year Ago EPS $-1.04 $-0.90
Year Over Year Growth Estimate -13.04% -4.44%
Current Qtr
(12/2021)
Next Qtr
(03/2022)
Current Year
(12/2021)
Next Year
(12/2022)
Consensus Estimate $-0.25 $-0.26 $-0.90 $-0.86
# of Estimates 2 1 2 2
High Estimate $-0.23 $-0.26 $-0.88 $-0.65
Low Estimate $-0.27 $-0.26 $-0.92 $-1.07
Year Ago EPS $-0.19 $-0.19 $-1.04 $-0.90
Year Over Year Growth Estimate 33.90% 39.26% -13.04% -4.44%

Insider Information Summary

as of 12/31/1969
% Insiders - 24.51%
% Remaining Total Shares - 75.49%
Current 1 Month
Net Insider Transaction 0.00 0.00
Shares Bought 0.00 0.00
Shares Sold 0.00 0.00

Insider Activity

Transaction Date Insider/Title Transaction Type Market Value Shares Average Price Current Holdings

LATEST NEWS

Recent Articles from TheStreet

Squid Game Lead

Netflix Leans Into Korean Content Following Squid Games Success

Netflix plans to bring more than 25 new Korean shows and movies to its streaming service in 2022.

M&M's Lead

M&Ms Revamps Beloved Characters With Less Sexist Look

The two visibly female M&M characters will now throw "shine and not shade."

Meng Wanzhou is accused of misleading HSBC about Huawei's relationship with a company operating in Iran. Photo: Sam Tsang

HSBC Turns Neutral on U.S. Stocks Amid Economic Concerns

HSBC strategist Max Kettner is worried about slowing growth, rising bond yields and Federal Reserve tightening.

Ford Lead

Ford Stock Is Lower This Week. When to Buy the Dip? The Chart Hints.

Ford stock is down about 10% so far this week. Is this an opportunity for the bulls or do they need to see more downside first?

Allbirds Lead

Most Americans Shopped At A Direct To Consumer Brand in 2021

Even traditional brands like Nike have moved more to a DTC model.

Jim Cramer: Peloton Is 'Overly Hated'

Peloton Stock Craters Following Report of Production Halt, Waning Fitness Demand

Peloton shares hit a two-year low Thursday after CNBC reported the group will temporarily pause production of its connected fitness equipment amid a "significant" slump in consumer demand.

Eric Adams Bitcoin Lead

New York Mayor to Get First Paycheck in Crypto

Mayor Eric Adams says he wants New York to be 'the center of cryptocurrency.'

Citigroup Lead

Goldman, Citi and Others Ask U.K. Workers to Return to Offices

Major companies, like Goldman and Citi, are asking workers to return to their offices after the U.K. government dropped its work-from-home guidance.

Good News for Homeowners: Housing Prices Continue to Climb

NYC, Chicago Area Housing Markets Seen as Unaffordable -- and Vulnerable

The Chicago and New York City areas each had eight of the most at-risk housing counties on a list created by data firm Attom.

Fantasy Sports Fans Can't Play Their Games in New York Today

1 Sports Betting Stat May Help MGM, Caesars, DraftKings Investors

The share of adults who said they bet on sports, regardless of frequency, rose to 25% in December from 20% in January.